Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05330429
Title Study of Magrolimab Given Together With FOLFIRI/BEV in Participants With Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Gilead Sciences
Indications

colorectal cancer

colorectal adenocarcinoma

Therapies

Bevacizumab + Fluorouracil + Irinotecan + Leucovorin

Bevacizumab + Fluorouracil + Hu5F9-G4 + Irinotecan + Leucovorin

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST